ArticleResearch square2026

DSTYK predicts Chemoresistance in Triple-Negative Breast Cancer Patient-Derived Xenograft Models.

Samuel Rojas et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.